Abstract:Abstract Background Due to the increased risk of viral infection and the severe shortage of medical resources during the pandemic of COVID-19, most hospitals in the epidemic areas significantly reduced non-emergency admissions and services, if not closed. As a result, it has been difficult to treat cancer patients on time, which adversely affects their prognosis. To address this problem, cancer centers must develop a strategic plan to manage both inpatients and outpatients during the pandemic, provide them with the necessary treatment, and at the same time prevent the spread of the virus among patients, visitors and medical staff. Methods Based upon the epidemic situation in Zhejiang Province, China, the number of running non-emergency medical wards in the Zhejiang Cancer Hospital was gradually increased in a controlled manner. All staff of the hospital received COVID-19 preventive training and was provided with three different levels of protection according to the risks of their services. Only patients without a known history of SARS-CoV-2 contact were eligible to schedule an appointment. Body temperature was measured on all patients upon their arrival at the hospital. Chest CT image, blood cell counting and travel/contact history were investigated in patients with fever. Respiratory tract samples, such as sputum and throat swabs, from all patients, including those clinically suspected of SARS-CoV-2 infection, were collected for nucleic acid detection of SARS-CoV-2 before treatment. Results A total of 3697 inpatients and 416 outpatients seeking cancer treatment were enrolled from February 1 to April 3, 2020, in compliance with the hospital’s infection-control interventions. The clinicopathological parameters of the patients were summarized herein. 4237 samples from 4101 patients produced negative RNA testing results. Four clinically suspected patients all presented negative RNA test results and were excluded from the SARS-CoV-2 infection through follow-up retesting and monitoring. Seven patients with only N-gene positive results were retested, followed by CT scan and SARS-CoV-2 contact history investigation. All of them were finally diagnosed as non-infected patients. There was one outpatient who was confirmed positive by virus RNA test and then followed up. She might be an asymptomatic laboratory-confirmed case. During the study period, there was no SARS-CoV-2 infection among staff, patients and escorts of patients in the Zhejiang Cancer Hospital. Conclusion This study suggested our infection-control interventions, including viral nucleic acid test, could be used as a reliable method to screen cancer patients in the area with moderate COVID-19 prevalence. Cancer may not be a high-risk factor of SARS-CoV-2 infection.

Treatment and Prevention Strategies for Patients with Gynecological Malignancies During the COVID-19 Pandemic

Recommendations on Management of Gynecological Malignancies During the COVID-19 Pandemic: Perspectives from Chinese Gynecological Oncologists

[Management strategies for patients with gynecological malignancies during the outbreak of COVID19].

[Management strategies for three patients with gynecological malignancies during the outbreak of COVID-19].

Treatment Strategies for Gastric Cancer During the COVID-19 Pandemic

Six Gynecological Cancer Patients Infected With SARS-CoV-2 After Surgery or Radio-/Chemo-Therapy Treatment: Case Series

Recommendation of radiotherapy for gynecological cancer during the COVID-19 epidemic

Multidisciplinary Treatment of Breast Cancer under COVID-19 Pandemic

Prevention and control strategies for the diagnosis and treatment of cancer patients during the COVID-19 pandemic

Pharmacological Prophylaxis and Personal Protective Equipment (PPE) Practices in Gynecological Cancer Surgery During COVID-19 Pandemic

Gynecological Prevention and Control Model Based on Ward Rearrangement and Zoning Management in Pandemic Period of COVID-19.

Gynecologic cancer surveillance in the era of SARS-CoV-2 (COVID-19)

Management of Gynecology Patients during COVID-19 Pandemic: Chinese Expert Consensus.

Challenges and countermeasures of thoracic oncology in the epidemic of COVID-19

Coronavirus Disease 2019 (COVID-19): Prevention and Control in Gynecological Outpatient Clinic

[Surgical Treatment Strategy for Digestive System Malignancies During the Outbreak of COVID-19].

Cancer Patient Management Strategy in a Cancer Center of Zhejiang, China During the COVID-19 Pandemic&nbsp;

Cancer patient management strategy in a Cancer Center of Zhejiang, China during the COVID-19 pandemic

The aggressive surgical treatment and outcome of a colon cancer patient with COVID-19 in Wuhan, China

Clinical Considerations for the Management of Cancer Patients in the Mitigation Stage of the COVID-19 Pandemic.

A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: an International Collaborative Group.